Publications du CNR en 2015

Amarsy-Guerle, R., Mougari, F., Jacquier, H., Oliary, J., Benmansour, H., Riahi, J., Berçot, B., Raskine, L. and Cambau, E. (2015). High medical impact of implementing the new polymeric bead-based BacT/ALERT® FAPlus and FNPlus blood culture bottles in standard care. European Journal of Clinical Microbiology & Infectious Diseases 34, 1031–1037, http://doi.org/10.1007/s10096-015-2319-8.

Bernard, C., Veziris, N., Brossier, F., Sougakoff, W., Jarlier, V., Robert, J. and Aubry, A. (2015). Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 59, 1519–1524, http://doi.org/10.1128/AAC.04058-14.

Brossier, F., Sola, C., Bernard, C., Jarlier, V., Veziris, N. and Sougakoff, W. (2015). Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (−15C→T) Ed. Land, G. A. Journal of Clinical Microbiology 53, 3104–3104, http://doi.org/10.1128/JCM.01537-15.

Brossier, F., Sougakoff, W., Bernard, C., Petrou, M., Adeyema, K., Pham, A., Amy de la Breteque, D., Vallet, M., Jarlier, V., Sola, C. and Veziris, N. (2015). Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France. Antimicrobial Agents and Chemotherapy 59, 4800–4808, http://doi.org/10.1128/AAC.00150-15.

Bui, T. V., Lévy-Bruhl, D., Che, D., Antoine, D., Jarlier, V. and Robert, J. (2015). Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011. Euro Surveill 20.

Cambau, E., Viveiros, M., Machado, D., Raskine, L., Ritter, C., Tortoli, E., Matthys, V., Hoffner, S., Richter, E., Perez Del Molino, M. L., Cirillo, D. M., van Soolingen, D. and Bottger, E. C. (2015). Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study. Journal of Antimicrobial Chemotherapy 70, 686–696, http://doi.org/10.1093/jac/dku438.

Catho, G., Couraud, S., Grard, S., Bouaziz, A., Sénéchal, A., Valour, F., Perpoint, T., Braun, E., Biron, F., Ferry, T., Chidiac, C., Freymond, N., Perrot, E., Souquet, P.-J., Maury, J.-M., Tronc, F., Veziris, N., Lina, G., Dumitrescu, O. and Ader, F. (2015). Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting. Clinical Microbiology and Infection 21, 472.e7-472.e10, http://doi.org/10.1016/j.cmi.2014.12.022.

Coolen, N., Morand, P., Martin, C., Hubert, D., Kanaan, R., Chapron, J., Honoré, I., Dusser, D., Audureau, E., Veziris, N. and Burgel, P.-R. (2015). Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. Journal of Cystic Fibrosis 14, 594–599, http://doi.org/10.1016/j.jcf.2015.02.006.

Grard, S., Catho, G., Valour, F., Bouaziz, A., Perpoint, T., Braun, E., Biron, F., Miailhes, P., Ferry, T., Chidiac, C., Souquet, P.-J., Couraud, S., Lina, G., Goutelle, S., Veziris, N., Dumitrescu, O. and Ader, F. (2015). Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four? Open Forum Infectious Diseases 2, ofv175, http://doi.org/10.1093/ofid/ofv175.

Guglielmetti, L. and Robert, J. (2015). Bédaquiline : de l’in vitro aux essais cliniques d’un nouvel antituberculeux. Journal des Anti-infectieux 17, 60–66, http://doi.org/10.1016/j.antinf.2014.12.003.

Guglielmetti, L., Mougari, F., Lopes, A., Raskine, L. and Cambau, E. (2015). Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists’ point of view. Future Microbiology 10, 1467–1483, http://doi.org/10.2217/fmb.15.64.

Guglielmetti, L., Dû, D. L., Jachym, M., Henry, B., Martin, D., Caumes, Eric, Veziris, Nicolas, Métivier, N., Robert, J., Andrejak, C., Bernard, C., Brossier, F., Chadelat, K., Dautzenberg, B., Jarlier, V., Raskine, L., Rivoire, B., Veziris, N., Appere, C., Assouline, P., Borie, R., Boukari, L., Caseris, M., Caumes, E., Douadi, Y., Dumoulin, J., Duval, C., Faucher, J. F., Gallien, S., Godet, C., Grusse, J. L., Lopes, A., Meynard, J. L., Naccache, J. M., Philippe, B., Richaud, C. and Saad, H. (2015). Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort. Clin Infect Dis 60, 188–194, http://doi.org/10.1093/cid/ciu786.

Hervé, C., Bergot, E., Veziris, N. and Blanc, F.-X. (2015). La tuberculose en 2015 : du diagnostic à la détection des formes résistantes. Revue des Maladies Respiratoires 32, 784–790, http://doi.org/10.1016/j.rmr.2015.06.008.

Isaakidis, P., Casas, E. C., Das, M., Tseretopoulou, X., Ntzani, E. E. and Ford, N. (2015). Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease 19, 969–978, http://doi.org/10.5588/ijtld.15.0123.

Jaubert, J., Mougari, F., Picot, S., Boukerrou, M., Barau, G., Ali Ahmed, S.-A., Raskine, L., Camuset, G., Michault, A., Simac, C. and Cambau, E. (2015). A case of postoperative breast infection by Mycobacterium fortuitum associated with the hospital water supply. American Journal of Infection Control 43, 406–408, http://doi.org/10.1016/j.ajic.2014.12.023.

Kibleur, Y. and Veziris, N. (2015). French Nationwide Cohort Temporary Utilization Authorization Survey of GranuPAS® in MDR-TB Patients. Chemotherapy 60, 174–179, http://doi.org/10.1159/000371869.

Reibel, F., Cambau, E. and Aubry, A. (2015). Histoire et actualité du traitement de la lèpre. Journal des Anti-Infectieux 17, 91–98, http://doi.org/10.1016/j.antinf.2015.01.004.

Reibel, F., Cambau, E. and Aubry, A. (2015). Update on the epidemiology, diagnosis, and treatment of leprosy. Médecine et Maladies Infectieuses 45, 383–393, http://doi.org/10.1016/j.medmal.2015.09.002.

Reibel, F., Chauffour, A., Brossier, F., Jarlier, V., Cambau, E. and Aubry, A. (2015). New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories Ed. Johnson, C. PLOS Neglected Tropical Diseases 9, e0004141, http://doi.org/10.1371/journal.pntd.0004141.

Renvoisé, A., Brossier, F., Galati, E., Veziris, N., Sougakoff, W., Aubry, A., Robert, J., Cambau, E., Jarlier, V. and Bernard, C. (2015). Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex. Antimicrobial Agents and Chemotherapy 59, 7153–7155, http://doi.org/10.1128/AAC.01027-15.

Robert, J. and CNR-MyRMA (2015). Résistance aux antituberculeux en France en 2013. Bulletin Epidémiologique Hebdomadaire 9–10, 172–174, URL: http://www.invs.sante.fr/beh/2015/9-10/pdf/2015_9-10_4.pdf.

Roux, A.-L., Catherinot, E., Soismier, N., Heym, B., Bellis, G., Lemonnier, L., Chiron, R., Fauroux, B., Le Bourgeois, M., Munck, A., Pin, I., Sermet, I., Gutierrez, C., Veziris, N., Jarlier, V., Cambau, E., Herrmann, J.-L., Guillemot, D. and Gaillard, J.-L. (2015). Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis 14, 63–69, http://doi.org/10.1016/j.jcf.2014.07.004.